跳至主要内容
临床试验/EUCTR2020-002699-10-DK
EUCTR2020-002699-10-DK进行中(未招募)1 期

High dose Ropivacaine versus moderate dose for quadratus lumborum block as postoperative analgesia after percutaneous nephrolithotomy – a blinded randomized non-inferiority study

未提供0 个研究点目标入组 28 人开始时间: 2020年10月8日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Scheduled for percutaneous nephrolithotomy
  • Males/females
  • Aged > 18 years
  • American Society of Anesthesiology (ASA) physical status 1 - 3
  • Legally competent
  • Fertile women using contraception OR a negative pregnancy test (HCG)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 8

排除标准

  • Age < 18 years
  • ASA physical status =4
  • Allergic to local anesthetics
  • Tattoos, infection or other abnormalities at the site of injection
  • No informed consent or inability to give that
  • Pre-existing use of opioids
  • Pregnant women
  • Severe liver disease

研究者

发起方
未提供

相似试验